Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Diagnos Inc. (V:ADK)

Business Focus: IT Services & Consulting (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for ADK within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 01, 2022 09:30 ET
DIAGNOS Announces Closing of Private Placement
DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that it has closed a...
Read full article
Aug 18, 2022 12:26 ET
DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems
DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to announce the...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.03
--
--
Price to Sales - TTM
27.21
6.13
5.60
Price to Book - most recent quarter
--
2.66
2.25
Price to Cash Flow per share - TTM
--
14.37
10.39
Price to Free Cash Flow per share - TTM
--
17.95
18.75
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 202287-48,554
Aug 31, 202248,64119,321
Aug 15, 202229,32020,320
See Short Report

Business Summary

Sector:  Technology Industry:  IT Services & Consulting

DIAGNOS Inc. is a Canada-based company that is engaged in early detection of health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as CARA (Computer Assisted Retina Analysis). The Company markets CARA, a software platform which assists health specialists in the detection of diabetic retinopathy. CARA is an in-house hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. CARA offers payers and patients in automating the screening process. The CARA suite of applications allows an eye care specialist to clearly visualize both normal retinal landmarks, such as optic nerve, vascular system, macula, fovea, as well as pathological changes (exudates, hemorrhages, micro-aneurisms, neo-vascularization). The Company also offers data mining consulting services in the natural resources sector.

See business summary

 

Twitter

Search (past week) for $ADK.CA ADK.V